Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cardiovascular Systems, Inc. - Common Stock (NQ: CSII )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cardiovascular Systems, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Cardiovascular Systems, Inc. Announces Development of Intravascular Lithotripsy Technology for the Treatment of Coronary and Peripheral Artery Diseases
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems Recalls Embolic Protection Devices Due To Filter Breakage
Cardiovascular Systems Inc (NASDAQ: CSII) is recalling all of its Wirion embolic protection system devices manufactured and distributed between January and November... 
Via Benzinga
CORRECTING and REPLACING Cardiovascular Systems, Inc. to Webcast Fiscal 2022 Second-Quarter Earnings Conference Call Thursday, February 3
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. to Webcast Fiscal 2022 Second-Quarter Earnings Conference Call Thursday, February 3
From Cardiovascular Systems, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap... 
Via Benzinga
Cardiovascular Systems Recalls Wirion Embolic Protection System
Cardiovascular Systems Inc (NASDAQ: CSII) has commenced a voluntary recall of its WIRION Embolic Protection Systems (WIRION). The unused WRN-D6 models of the... 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2021
Upgrades According to Williams Capital, the prior rating for On Holding AG (NYSE: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2021
Upgrades HC Wainwright & Co. upgraded the previous rating for BioNTech SE (NASDAQ: 
Via Benzinga
75 Biggest Movers From Yesterday
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Check out these big penny stock gainers and losers... 
Via Benzinga
Cardiovascular Systems, inc (CSII) Q1 2022 Earnings Call Transcript
CSII earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
Cardiovascular Systems, Inc. Reports Fiscal 2022 First Quarter Financial Results
From Cardiovascular Systems, Inc.
Via Business Wire
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... 
Via Benzinga
Cardiovascular Systems, Inc. Announces First In-Human Experience With Coronary Everolimus Drug Coated Balloon
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. to Participate at the Stifel 2021 Virtual Healthcare Conference
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. to Webcast Fiscal 2022 First-Quarter Earnings Conference Call Tuesday, November 9
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. Announces First Patient Treated with ViperCross™ Peripheral Support Catheter
From Cardiovascular Systems, Inc.
Via Business Wire
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (... 
Via Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (... 
Via Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Acceleron Pharma Inc. (... 
Via Benzinga
Exposures COVID-19
Cardiovascular Systems Expects COVID-19 Impact On Quarterly Revenue
Cardiovascular Systems Inc (NASDAQ: CSII) issued an update on financials citing the COVID-19 impact. The device maker says that the revenue for Q1 FY22 could be negatively... 
Via Benzinga
Exposures COVID-19
First Patients in Canada Treated With Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, inc (CSII) Q4 2021 Earnings Call Transcript
CSII earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Cardiovascular Systems, Inc. Reports Fiscal 2021 Fourth Quarter and Full Year Financial Results
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. to Attend Three Investor Conferences in August
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. to Webcast Fiscal 2021 Fourth-Quarter Earnings Conference Call Wednesday, August 4
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. to Participate at the Raymond James Human Health Innovations Conference
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. Announces U.S. Commercial Launch of JADE Over-the-Wire Non-Compliant Peripheral Balloon Catheters
From Cardiovascular Systems, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.